Small-Cap Catalysts to Watch: April 14 - April 18

Catch up on this week’s must-watch catalysts and events, all pulled from the freshest filings and press releases—stay in the know and one step ahead!

Companies participating at the Jefferies Power x Coin Virtual Conference on April 16, 2025:

WULF (also attending Data Center World in Washington, DC from April 14–17, 2025)

FUFU

Companies presenting at the Emerging Growth Conference on April 17, 2025:

SBC, BNZI

Other companies with key Catalysts this week:

AMIX > An abstract highlighting the company’s technology and early proof-of-concept study results has been accepted for poster presentation at the 2025 European Conference on Interventional Oncology (ECIO), taking place April 13–16, 2025 in Rotterdam, Netherlands.

IBRX > The company will host its Investor Day on Tuesday, April 15, 2025, at 10:00 AM PDT. The event will feature detailed updates on business operations and global regulatory progress of its clinical-stage products, along with fireside chats led by Dr. Patrick Soon-Shiong and key opinion leaders involved in the company’s research programs.

AXL > Will participate in the BofA Securities 2025 Global Automotive Summit on April 15.

OCGN > Will present at the 2025 Cell & Gene Meeting on the Mediterranean being held April 15-17, 2025.

ADUR > The company will participate at the Canadian Circular Economy Summit, taking place April 15–17, 2025, in Montreal, Quebec.

INO > The company will participate in the National HPV Conference on April 15, 2025, in Indianapolis, IN, with an oral presentation on INO-3107 showing a 72% Year 1 response rate for RRP caused by HPV-6 & 11, and a panel on clinical advances moderated by Kim McClellan, President of the RRP Foundation.

BNGO > Bionano will host an In-Motion Webinar on April 15, 2025, at 9:30 AM Central Time, featuring Dr. Guilin Tang, the study’s lead author, who will discuss the study's findings and the potential implications for widespread adoption of optical genome mapping.

SXTP > Will participate in a scientific discussion on the management and treatment of babesiosis during the April 15–21 Healing Lyme Summit.

PSQH > Michael Seifert, Chairman and Chief Executive Officer, will participate in the upcoming Emerging Growth Conference on Wednesday, April 16, 2025.

LPTH > Jason Liebert – General Manager of the Plano, Texas facility – will present at the virtual Photonics Spectra Infrared Imaging Summit 2025 on April 16, 2025.

FBLG > The company will present on FibroBiologics' unique fibroblast cell-based approach for the potential treatment of chronic diseases at The Cell & Gene Meeting on the Mediterranean, taking place in Rome, Italy, from April 15–17, 2025.

IRIX > The company will host a special call on April 16, 2025, to introduce Iridex and Novel's strategic vision for the company following Novel's recent strategic investment in Iridex.

LIDR > The company will participate in Bank of America's 2025 Global Automotive Summit, taking place on April 16, 2025, in New York, NY.

SMTK > The company is positioned to unveil the first MicroLED-in-a-Package (MiP) Backlight using Smartkem's unique and proprietary technology at this year's Touch Taiwan conference in Taipei City, Taiwan, running from April 16-18, 2025.

NBY > The company will hold a special meeting on April 16, 2025, to seek stockholder approval for the dissolution under the Plan of Dissolution. Even if approved, the Board may choose to abandon the dissolution if it’s no longer deemed in the company’s best interest. If the dissolution is not approved or abandoned, the company will explore other strategic alternatives or may file for bankruptcy protection.

EGY > George Maxwell, Chief Executive Officer, and Ron Bain, Chief Financial Officer, will provide a live presentation via Investor Meet Company on Thursday, April 17, 2025.

SLDB > Management will participate in one-on-one meetings on Thursday, April 17, 2025, at the Piper Sandler Spring Biopharma Symposium in Boston, MA.

AVTE > Aerovate has announced a cash dividend of $69.6 million, or approximately $2.40 per share, payable to stockholders of record as of April 25, 2025, with a payment date of April 29, 2025. The dividend is based on 28,985,019 shares outstanding as of April 9, 2025, and will be characterized as a return of capital, not a taxable dividend. The dividend payment is contingent upon the closing of Aerovate's merger with Jade Biosciences, Inc., which is expected to occur on or about April 28, 2025, assuming stockholder approval and the satisfaction of all merger conditions. A special stockholder meeting to vote on the merger is scheduled for 9:00 a.m. ET on April 16, 2025.

AQST > The management team will participate in the Piper Sandler Spring Biopharma Symposium in Boston, where the Aquestive team will host investor meetings on April 17, 2025.

BTTR > The Board of Directors has approved a stock dividend of 0.35 per share for every 1 share of common stock, payable to stockholders of record as of Thursday, April 17, 2025. Due to administrative and regulatory requirements, the payable date has been changed to April 21, 2025. The shares will trade with a due bill from April 17 through April 21, 2025 (the "due bill period"), and the ex-dividend date will be April 22, 2025. Stockholders of record on April 17, 2025, must hold their shares through the payment date of April 21, 2025, to receive the dividend. The record date remains unchanged.

KOPN > The company will participate in the SPIE Defense and Commercial Sensing 2025 exhibition, taking place from April 15-17, 2025, at the Gaylord Palms Resort & Convention Center in Orlando, Florida.

ATYR > The company will participate in the Piper Sandler Spring Biopharma Symposium on April 17, 2025, in Boston, MA, hosting 1x1 investor meetings.

TROO / WLGS > TROOPS, Inc. has received the initial tranche of a strategic investment exceeding $10 million from Wang & Lee Group, with full completion expected by mid-April 2025, supporting their partnership to integrate AI, IoT, and blockchain technologies across TROOPS’ portfolio.

LEDS > SCIVAX Corporation and TSLC Corporation, a wholly owned subsidiary of SemiLEDs Corporation, have developed the world's smallest PPG (PhotoPlethysmoGraphy) sensor head, which will be showcased at the Touch Taiwan exhibition in Taipei from April 16–18, 2025, with evaluation samples available starting in April 2025.

OMEX > The company will present at the Emerging Growth Conference on April 16, 2025.

ALLK > Allakos has agreed to be acquired by Concentra Biosciences for $0.33 per share in cash, with a tender offer launching by April 15, 2025. The deal, backed by 8.07% of insider shares, requires a majority of shares tendered and at least $35.5M in net cash at closing. The merger is expected to close in May 2025.

LITM > Snow Lake provides an update on its 50/50 joint venture with Global Uranium and Enrichment Limited (GUE) on the Pine Ridge Uranium Project in Wyoming. GUE has staked additional mineral claims, expanding the project to nearly 20,000 acres. GUE will hold a general meeting on April 14, 2025, to seek approval for both the joint venture and a A$10 million equity raise for the Pine Ridge acquisition, with a tentative closing date of April 22, 2025. Snow Lake has committed A$5.8 million for a 19.99% interest in GUE as part of the raise.

VCIG > Building on this momentum, VCI Global is capitalizing on the rising demand for AI infrastructure. The company will launch its AI Integrated Server, followed by the AI Cloud Platform on April 18, 2025.

TOON > Kartoon Studios will partner with Vue Cinemas to debut the world’s first feature-length game show movie, Kartoon Channel's Gaming Challenge UK, premiering this Easter. The 85-minute film features British children aged nine to 11 playing custom-built Roblox levels and will be shown at Vue Cinemas across the UK and ROI starting April 19, 2025.

THTX > On January 9, 2025, the Company announced a temporary supply disruption for EGRIFTA SV® due to a voluntary shutdown of its contract manufacturer's facility following an FDA inspection in 2024. Manufacturing resumed in November 2024, and the Company filed a PAS with the FDA. The PDUFA goal date is set for April 18, 2025.

MTVA > Top-line data from MAD Part 2 of the Phase 1 trial of DA-1726 is expected in April 2025.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.